Cerulean Pharma Shares Gap Up Following Better-Than-Expected Earnings (CERU)
Cerulean Pharma (NASDAQ:CERU)’s share price gapped up before the market opened on Wednesday following a stronger than expected earnings report, Analyst Ratings.Net reports. The stock had previously closed at $3.34, but opened at $3.46. Cerulean Pharma shares last traded at $4.16, with a volume of 21,820 shares.
The company reported ($0.34) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.36) by $0.02.
The stock has a 50-day moving average of $4.85 and a 200-day moving average of $5.82. The company’s market cap is $84.7 million.
Cerulean Pharma Inc is a clinical-stage oncology-focused company applying its tumor targeting platform.
Receive News & Ratings for Cerulean Pharma Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerulean Pharma Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.